TRCT
AIFF

Tower Research Capital (TRC)’s Firefly Neuroscience AIFF Stock Holding History

Tower Research Capital (TRC)’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.17K Buy
5,926
+3,194
+117% +$5.57K ﹤0.01% 4147
2026
Q1 		$5.96K Buy
2,732
+70
+3% +$87 ﹤0.01% 4087
2025
Q4 		$2.33K Buy
2,662
+446
+20% +$832 ﹤0.01% 4551
2025
Q3 		$6.45K Sell
2,216
-860
-28% -$2.44K ﹤0.01% 4160
2025
Q2 		$8.71K Buy
3,076
+1,567
+104% +$4.97K ﹤0.01% 4012
2025
Q1 		$5.93K Sell
1,509
-281
-16% -$1.29K ﹤0.01% 4078
2024
Q4 		$4.74K Buy
1,790
+486
+37% +$1.51K ﹤0.01% 4405
2024
Q3 		$3.96K Buy
1,304
+257
+25% +$1.35K ﹤0.01% 4720
2024
Q2 		$6.5K Buy
1,047
+571
+120% +$4.25K ﹤0.01% 4571
2024
Q1 		$4.94K Sell
476
-1,777
-79% -$11.9K ﹤0.01% 4610
2023
Q4 		$11.4K Buy
2,253
+1,991
+760% +$12.9K ﹤0.01% 4132
2023
Q3 		$2.04K Hold
262
– – ﹤0.01% 5226
2023
Q2 		$2.4K Sell
262
-3
-1% -$34 ﹤0.01% 5206
2023
Q1 		$2K Buy
265
+3
+1% +$59 ﹤0.01% 5418
2022
Q4 		$4K Sell
262
-40
-13% -$931 ﹤0.01% 5088
2022
Q3 		$8K Buy
302
+147
+95% +$5.39K ﹤0.01% 4822
2022
Q2 		$6K Sell
155
-132
-46% -$12.7K ﹤0.01% 4968
2022
Q1 		$46K Buy
+287
New +$38.8K ﹤0.01% 2811

Other funds holding AIFF

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCA
Cygnus Capital Advisors Atlanta, Georgia $147M AUM

Tower Research Capital (TRC)'s AIFF Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Firefly Neuroscience (AIFF) stake by 117% in Q2 2026, buying an estimated $5.57K and bringing the position to 5,926 shares worth $7.17K. The position accounts for ﹤0.01% of the portfolio, ranked #4147.

Tower Research Capital (TRC) first reported a position in AIFF in Q1 2022 and has held it in 18 quarters since. The position peaked at $46K in Q1 2022. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

  • Tower Research Capital (TRC) held 5,926 shares of Firefly Neuroscience worth $7.17K as of Q2 2026.
  • Tower Research Capital (TRC) bought 3,194 Firefly Neuroscience shares in Q2 2026, an estimated $5.57K.
  • Firefly Neuroscience made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4147 holding.
  • Tower Research Capital (TRC) first reported a position in Firefly Neuroscience in Q1 2022 and has held it in 18 quarters since.
  • Tower Research Capital (TRC)'s Firefly Neuroscience position peaked at $46K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.